Contact Us

Canadian Immunohistochemistry Quality Control
Department of Pathology and Laboratory Medicine
University of British Columbia
G408-2211 Wesbrook Mall
Vancouver, BC, V6T 2B5
Toll Free*: 1-844-822-CIQC (2472)
Fax: 604-827-1338
Fax Toll Free*: 1-866-580-2678

*Toll free within Canada and USA only

For any inquiries, please contact Jennifer Won at jennifer.won@ciqc.ca

The History of cIQc

Founded by Drs. Emina Emilia Torlakovic and Blake Gilks, the Canadian Immunohistochemistry Quality Control (cIQc) builds on existing work to systematically monitor and improve the proficiency of immunohistochemistry (IHC) testing across the country. Creation of this Canada-wide quality assessment program will facilitate participation by IHC labs nationwide and, eventually, by international stakeholders, regardless of jurisdiction or existing accreditation requirements.

The cIQc has been supported from its inception by the College of Medicine, University of Saskatchewan and is endorsed by the Canadian Association of Pathologists.

Since April 2009 it has been made available to all Canadian clinical IHC laboratories in collaboration with the Canadian Partnership Against Cancer.

The cIQc Team

Emina Emilia Torlakovic, MD, PhD, FCAP – Co-Director
Emina Emilia Torlakovic, MD, PhD, is the Division Head - Hematopathology and Professor, College of Medicine at the University of Saskatchewan. She is a Diplomate of the American Board of Pathology in Anatomical and Clinical Pathology and Hematopathology. She has authored over 100 peer-reviewed manuscripts and also published author of book/book chapters. She led several national and international published guidelines in the field of immunohistochemistry and is also a co-author of ASCO/CAP guidelines for ER/PR testing in breast cancer. Dr. Torlakovic is a founding member of NordiQC, as well as the International Society for Immunohistochemistry and Molecular Morphology (ISIMM). She is the Chair of the Canadian Association of Pathologists’ National Standards Committee for High Complexity Laboratory Testing and also co-directs cIQc. She has widely lectured in the field of quality assurance as well as in hematopathology. She is also internationally recognized for her seminal work in and discovery of sessile serrated adenoma.

emina.torlakovic@ciqc.ca
​Blake Gilks, MD, FRCPC – Co-Director
​Dr. Blake Gilks is a Professor in the Department of Pathology and Laboratory Medicine at the University of British Columbia and Division Head, Anatomic Pathology, at Vancouver General Hospital, the site of the largest surgical oncology program in the province. Dr. Gilks leads a research program focused on gynecological cancers and is co-founder of OvCaRe, a multidisciplinary team studying ovarian cancer. In addition, he is also a co-founder of the Genetic Pathology Evaluation Centre, a collaborative research venture of the Pathology Department, the Prostate Research Centre of the Vancouver General Hospital, and the BC Cancer Agency, utilizing tissue microarray technology to uncover novel cancer biomarkers.

blake.gilks@ciqc.ca
​John Garratt, RT (Cyto) – Manager
For many years ​John Garratt was the Anatomic Pathology Technical Specialist for Vancouver Coastal Health, for which there are four surgical pathology laboratories in the health region with a combined volume of over 80,000 cases per annum. In his retirement he has remained actively involved in the development and maintenance of standards in Surgical Pathology and Diagnostic Cytology with the Diagnostic Accreditation Program of British Columbia, as well as his invaluable contribution to the cIQc team.

john.garratt@ciqc.ca
Jennifer Won, PhD, BSc, DipT – Project Coordinator
Jennifer Won is the cIQc’s first employee thanks to funding from the Canadian Partnership Against Cancer. She completed her graduate studies under the supervision of Dr. Torsten Nielsen at the Genetic Pathology Evaluation Centre. Her dissertation began as an investigation of novel diagnostic, prognostic and predictive biomarkers for hormone-receptor negative breast cancers, but evolved into a project focused on breast cancer biomarker clinical utility and quality assurance in hospital laboratories.

jennifer.won@ciqc.ca

Canadian Immunohistochemistry Quality Control